Cadmium Exposure and Neurodevelopmental Outcomes in U.S. Children by Ciesielski, Timothy et al.
 
Cadmium Exposure and Neurodevelopmental Outcomes in U.S.
Children
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Ciesielski, Timothy, Jennifer Weuve, David C. Bellinger, Joel
Schwartz, Bruce Lanphear, and Robert O. Wright. 2012.
Cadmium exposure and neurodevelopmental outcomes in U.S.
children. Environmental Health Perspectives 120(5): 758-763.
Published Version doi:10.1289/ehp.1104152
Accessed February 19, 2015 10:32:24 AM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:10378066
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-
of-use#LAA758  v o l u m e  120 | n u m b e r 5 | May 2012  •  Environmental Health Perspectives
Research | Children’s Health
Cadmium is a heavy metal found in the 
earth’s crust that is disseminated in the envi-
ronment both by natural processes and by 
human activities such as fossil fuel burning, 
waste incineration, smelting procedures, and 
the use of phosphate fertilizers (Agency for 
Toxic Substances and Disease Registry 2008). 
Uptake of environmental cadmium in plants 
and animals results in human exposures via 
food or tobacco smoke, and occupational 
exposures can occur as well [European Food 
Safety Authority (EFSA) 2009]. Cadmium 
is known to be nephrotoxic (EFSA 2009), 
but there is also a growing body of evidence 
suggesting that cadmium exposure may have 
adverse neurodevelopmental consequences.
Several animal studies have reported 
effects of cadmium on electrophysiologi-
cal parameters, markers of neurotransmit-
ter function, and neurobehavioral outcomes 
(Ali et al. 1986; Desi et al. 1998; Lehotzky 
et al. 1990; Nagymajtenyi et al. 1997; Nation 
et al. 1983, 1984, 1989, 1990). Studies in 
children have reported associations between 
higher cadmium levels and mental retarda-
tion (Jiang et al. 1990; Marlowe et al. 1983), 
decreased verbal IQ (Thatcher et al. 1982), 
lower neuropsychological test performance 
(Bonithon-Kopp et al. 1986; Stellern et al. 
1983), learning disability (LD) (Capel et al. 
1981; Ely et al. 1981; Pihl and Parkes 1977), 
poor reading performance (Thatcher et al. 
1984b), neurophysiological evoked poten-
tial differences (Thatcher et al. 1984a), and 
behavioral problems in the presence of con-
currently elevated lead levels (Marlowe et al. 
1985a). In contrast, other human studies 
have failed to detect significant multivari-
able-adjusted associations between markers of 
cadmium exposure and neurodevelopmental 
outcomes (Cao et al. 2009; Gillberg et al. 
1982; Lee et al. 2007; Marlowe et al. 1985b; 
Moon et al. 1985; Wright et al. 2006). These 
studies varied in size, quality, and design. In 
addition, they used several different expo-
sure metrics, evaluated different windows of 
susceptibility, and differed in their consider-
ation of potentially important confounders. 
These factors may help explain the inconsis-
tent results, and further research could help 
resolve some of the discrepancies.
In this study, we analyzed a large repre-
sentative sample of U.S. children 6–15 years 
of age from the National Health and 
Nutrition Examination Survey (NHANES), 
to determine whether higher levels of urinary 
cadmium were associated with attention 
deficit hyperactivity disorder (ADHD), LD, 
or placement in special education. To our 
knowledge, this is the largest study to evalu-
ate associations between urinary cadmium 
and neurodevelopmental outcomes, and the 
first to do so in a nationally representative 
sample of U.S. children.
Methods
Data source and study population. NHANES 
is an ongoing series of cross-sectional question-
naires, examinations, and laboratory analyses 
that evaluate nutritional and environmental 
exposures as well as various health parameters 
in the U.S. population [Centers for Disease 
Control and Prevention National Center for 
Health Statistics (CDC-NCHS) 2010b]. 
Detailed documentation on NHANES is 
available online (CDC-NCHS 2010b). For 
this study we used NHANES data collected 
1999–2004. We restricted our analyses to 
children 6–15 years of age because urinary 
cadmium was evaluated in a subsample of 
participants ≥ 6 years of age, and informa-
tion on several covariates was not available 
for participants > 15 years of age. There were 
2,282 children between 6 and 15 years of age 
in this subsample, and urine cadmium mea-
surements were available for 2,199 (96.4%) 
of these. Because some children were miss-
ing outcome data, 2,189, 2,196, and 2,195 
children were included in the analyses of LD, 
special education, and ADHD, respectively. 
The NHANES website notes that approval 
(protocol 98-12) was obtained from the 
NCHS Ethics Review Board (referred to as 
the NHANES Institutional Review Board 
before 2003) (CDC-NCHS 2012).
Exposure assessment. Cadmium exposure 
was assessed using urinary cadmium concen-
tration, which is an indicator of body burden/
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Ba c k g r o u n d: Low-level environmental cadmium exposure in children may be associated with 
adverse neurodevelopmental outcomes.
oB j e c t i v e: Our aim was to evaluate associations between urinary cadmium concentration and 
reported learning disability (LD), special education utilization, and attention deficit hyper  activity 
disorder (ADHD) in U.S. children using National Health and Nutrition Examination Survey 
(NHANES) data.
Me t h o d s : We analyzed data from a subset of participants in NHANES (1999–2004) who were 
6–15 years of age and had spot urine samples analyzed for cadmium. Outcomes were assessed by 
parent or proxy-respondent report. We fit multivariable-adjusted logistic regression models to esti-
mate associations between urinary cadmium and the outcomes.
re s u l t s: When we compared children in the highest quartile of urinary cadmium with those in the 
lowest quartile, odds ratios adjusted for several potential confounders were 3.21 [95% confidence 
interval (CI): 1.43, 7.17] for LD, 3.00 (95% CI: 1.12, 8.01) for special education, and 0.67 (95% 
CI: 0.28, 1.61) for ADHD. There were no significant interactions with sex, but associations with 
LD and special education were somewhat stronger in males, and the trend in the ADHD analysis 
was only evident among those with blood lead levels above the median.
co n c l u s i o n s: These findings suggest that children who have higher urinary cadmium concentra-
tions may have increased risk of both LD and special education. Importantly, we observed these 
associations at exposure levels that were previously considered to be without adverse effects, and 
these levels are common among U.S. children.
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cumulative cadmium exposure (Lauwerys 
et al. 1994). Urinary cadmium concentra-
tion was determined by inductively coupled 
plasma mass spectrometry (ICP-MS), and 
details are accessible online via the NHANES 
website (CDC-NCHS 2010b). The limit of 
detection (LOD) was 0.06 μg/L, and cad-
mium concentrations below the LOD were 
imputed as the LOD divided by the square 
root of 2. Of the 2,199 participants, 222 
(10%) had urinary cadmium concentrations 
below the LOD. Cadmium (Cd) concentra-
tions were corrected for interference from tin 
(Sn) and molybdenum (Mo), because these 
elements can produce ICP-MS signals (114Sn, 
98Mo16O+, 96Mo18O+, 97Mo17OH+) that 
overlap with 114Cd (CDC-NCHS 2010b; 
Jarrett et al. 2008). Cadmium concentrations 
that were below zero after molybdenum cor-
rection were left-truncated and listed as zero.
Urinary creatinine is often used to correct 
for the variation in chemical concentration 
that is attributable to variation in urine dilu-
tion when exposure estimates are based on 
spot urine samples (Barr et al. 2005). Because 
creatinine enters urine at a fairly constant rate, 
urine creatinine concentration is inversely 
proportional to urine flow rate and can be 
used to correct for differences in urine flow 
rate (Barr et al. 2005). In this study urine 
creatinine levels were determined via a Jaffé 
rate reaction with a Beckman Synchron CX3 
Clinical Analyzer (Beckman Instruments, 
Inc., Brea, CA, USA) (CDC-NCHS 2010b). 
As recommended by Barr et al. (2005), we 
included urine creatinine concentration as an 
independent covariate in the regression mod-
els rather than using the ratio of cadmium 
to creatinine (creatinine standardization), 
because this approach should be less likely 
to produce biased effect estimates (Barr et al. 
2005; Schisterman et al. 2005).
Outcomes. Assessment of neuro  develop-
mental outcomes was based on responses 
of parent, guardian, or other adult proxy 
responder (CDC-NCHS 2010b). For chil-
dren < 12 years of age, LD status was assessed 
with the following question: “Has a repre-
sentative from a school or health professional 
ever told [you] that [the child] had a learning 
disability?”; ADHD status was assessed as fol-
lows: “Has a doctor or health professional 
ever told [you] that [the child] had atten-
tion deficit disorder?” For those ≥ 12 years 
of age, the same questions were asked about 
LD and ADHD but the bracketed words 
were replaced with: [the child] and [he/she]. 
Special education utilization was assessed with 
the same question regardless of the child’s age: 
“Does [the child] receive Special Education or 
Early Intervention Services?”
Covariates. Data on many potential con-
founders were available in NHANES (CDC-
NCHS 2010b). We considered the following 
covariates in our analyses: age (years), sex, 
race/ethnicity [non-Hispanic white (referent), 
non-Hispanic black, Mexican American, other 
Hispanic, other race (including multiracial)], 
maternal age at birth of child (years), atten-
dance at preschool/daycare (yes/no), health 
insurance coverage (yes/no), receipt of neo-
natal intensive care unit or special newborn 
care (yes/no), low birth weight (< 2,500 g; 
yes/no), poverty income ratio (the ratio of 
family income to the federal poverty threshold; 
ratios ≥ 5 are listed as 5), education level of 
the household reference person (highest grade 
achieved: less than 9th grade, at least 9th grade 
but no high school diploma, high school grad-
uate/GED (general educational development) 
degree or equivalent, some college or associate 
of arts degree, and college graduate or above), 
blood lead level (micrograms per deciliter), 
low hemoglobin level for age and sex (< 10th 
percentile, ≥ 10th percentile; used as a proxy 
for iron deficiency), report of a smoker in the 
home (yes/no), serum cotinine (nanograms 
per milliliter), prenatal smoke exposure (i.e., 
the child’s mother smoked while pregnant; 
yes/no), and, as mentioned above, urine creati-
nine (milligrams per deciliter). Detailed infor-
mation on the covariates is available online 
(CDC-NCHS 2010b).
Statistical analysis. Analyses were con-
ducted using SAS (version 9.1.3; SAS Institute 
Inc., Cary, NC). We obtained national preva-
lence estimates for the outcomes by using the 
SURVEYMEANS procedure, specifying strata, 
cluster, and weight variables to account for the 
complex sampling design characteristics of 
NHANES (CDC-NCHS 2010a, 2010b). For 
each of the three outcomes, we estimated the 
relative odds of each outcome across quartiles 
of urinary cadmium concentration. To do this 
we fit multivariable-adjusted logistic regres-
sion models with the SURVEYLOGISTIC 
procedure, again specifying strata, cluster, 
and weight variables (CDC-NCHS 2010a, 
2010b). Urinary cadmium was evaluated in 
quartiles in order to allow for the detection of 
non  linear dose–response relationships, reduce 
the potential excess influence of data from 
children with very high cadmium concentra-
tions on the effect estimates, and alleviate con-
cerns about low cadmium levels in the context 
of molybdenum correction and left truncation 
of urinary cadmium levels at zero (when cor-
rection resulted in a cadmium concentration 
below zero).
We constructed three main models: 
a) logistic regression models relating urinary 
cadmium to each outcome adjusting only for 
urinary creatinine; b) core models adjusted 
for urinary creatinine, age, sex, blood lead, 
smoker in the home, serum cotinine, prenatal 
smoke exposure (mother smoked while preg-
nant), and poverty income ratio; and c) full 
models also adjusted for additional covariates 
of a priori interest that predicted outcomes 
(p < 0.10) in bivariate logistic regression mod-
els. Continuous and discrete covariates were 
modeled as single linear terms, except for 
hemoglobin levels. Low hemoglobin levels 
are a proxy for iron deficiency (Zimmermann 
2008). Because normal hemoglobin levels vary 
by age and sex (Ahsan and Noether 2011), we 
modeled hemoglobin in categories (< 10th 
percentile or ≥ 10th percentile for the age and 
sex of the participant).
Prior studies have suggested an interaction 
between cadmium exposure and sex in rela-
tion to LD, as well as an interaction between 
cadmium exposure and lead exposure in 
relation to ADHD (Ely et al. 1981; Nation 
et al. 1989, 1990). We evaluated cadmium–
sex and cadmium–lead interactions in the 
fully adjusted models by including product 
interaction terms with cadmium modeled as 
an ordinal trend variable (coded as 0, 1, 2, 
or 3 based on the quartile of exposure) to 
obtain p-values for each interaction. For the 
  cadmium–lead interaction, lead was also mod-
eled as an ordinal trend variable. To obtain a 
single (summary) effect estimate for urinary 
cadmium with each outcome, we evaluated 
this cadmium quartile trend variable in the 
fully adjusted models. We also evaluated this 
cadmium quartile trend variable in the fully 
adjusted models (with the sex or blood lead 
term removed) within strata defined by sex or 
blood lead level (above/below median). In our 
analyses statistical significance was defined as 
p < 0.05 or a 95% confidence interval (CI) 
that excluded the null.
Results
History of LD was reported for 12.6% 
(276 of 2,189) of the study population, 
and participation in special education was 
reported for 10.5% (231 of 2,196). History 
of ADHD diagnosis was reported for 9.0% 
(198 of 2,195) of the study population. The 
co-  occurrence of the outcomes is shown in 
Figure 1. Accounting for the complex sur-
vey design characteristics of NHANES, the 
estimated lifetime prevalence among U.S. 
children 6–15 years of age was 12.6% for 
LD (95% CI: 9.5%, 15.7%), 11.7% for spe-
cial education participation (95% CI: 9.5%, 
13.9%), and 11.5% for ADHD (95% CI: 
8.5%, 14.5%). Urinary cadmium concentra-
tions followed an approximately log-normal 
distribution, with a median of 0.11 μg/L, an 
interquartile range (IQR) of 0.06–0.18 μg/L, 
and a range of 0.00–14.94 μg/L. Urinary 
cadmium concentrations by covariate level 
are listed in Table 1. Urinary cadmium con-
centrations were generally higher among 
non-Hispanic black and Mexican-American 
children than among white children, and 
higher among children from more impov-
erished households or households where Ciesielski et al.
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the reference person had lower educational 
achievement (Table 1). Children with LD and 
children who participated in special educa-
tion had higher median urinary cadmium lev-
els, whereas children with ADHD had lower 
median urinary cadmium levels (Table 2).
Children in the two highest quartiles of 
urinary cadmium concentration had higher 
odds of LD and special education in both 
the creatinine-adjusted and fully adjusted 
analy  ses (Table 3). In contrast, children in the 
three highest quartiles of urinary cadmium 
concentration had lower odds of ADHD in 
the both the creatinine-adjusted and fully 
adjusted analyses (Table 3). When we com-
pared children in the highest quartile of urine 
cadmium concentration with those in the 
lowest quartile, the fully adjusted odds ratios 
(ORs) were 3.21 (95% CI: 1.43, 7.17) for 
LD, 3.00 (95% CI: 1.12, 8.01) for special 
education, and 0.67 (95% CI: 0.28, 1.61) for 
ADHD. Adding a term for low hemoglobin 
level to the fully adjusted models had little 
effect on these ORs and did not change the 
significance conclusions (data not shown). 
ORs from core models adjusted only for uri-
nary creatinine, age, sex, blood lead, smoker 
in the home, serum cotinine, prenatal smoke 
exposure (mother smoked while pregnant), 
and poverty income ratio were similar: 3.50 
(95% CI: 1.56, 7.88) for LD, 2.66 (95% CI: 
1.07, 6.63) for special education, and 0.65 
(95% CI: 0.28, 1.51) for ADHD.
When urinary cadmium was modeled with 
an ordinal tend variable (coded as 0, 1, 2, or 3 
based on the quartile of exposure), the fully 
adjusted ORs for a one-quartile increase in 
urinary cadmium were 1.51 (95% CI: 1.14, 
2.00) for LD, 1.44 (95% CI: 1.03, 2.01) for 
special education, and 0.84 (95% CI: 0.61, 
1.16) for ADHD (Table 4). In sex-stratified 
analyses, the corresponding ORs for LD and 
special education were somewhat larger among 
males than among females [for LD, 1.75 (95% 
CI: 1.24, 2.46) vs. 1.24 (95% CI: 0.75, 2.04) 
and for special education, 1.73 (95% CI: 1.02, 
2.92) vs. 1.31 (95% CI: 0.81, 2.13)]. In blood 
lead–stratified analyses, the corresponding OR 
for ADHD was 1.11 (95% CI: 0.65, 1.91) 
for those with lead levels below the median 
and 0.73 (95% CI: 0.52, 1.03) for those 
with lead above the median. However, these 
interactions were not significant (p = 0.71 for 
  cadmium–sex in the LD analysis, p = 0.43 for 
  cadmium–sex in the special education analy-
sis, and p = 0.43 for cadmium–lead in the 
ADHD analysis), and none of the remaining 
  cadmium–sex or   cadmium–lead inter  action 
terms were significant.
Discussion
LD and special education. We observed that 
children in the highest quartile of urinary cad-
mium had significantly higher odds of both 
LD and special education when compared 
with those in the lowest quartile. A few prior 
studies have linked cadmium exposure with 
LD, and these studies relied on hair and blood 
samples to assess cadmium exposure. Two 
case–control studies demonstrated higher hair 
cadmium concentrations in children with LD 
(Capel et al. 1981; Pihl and Parkes 1977). A 
third study also found higher hair cadmium 
concentrations in children with LD, but the 
difference was statistically significant only 
for males (Ely et al. 1981). In that study, the 
authors considered the sexes separately but did 
not present the type of statistical evaluation for 
interaction that we report here. Interestingly, 
in our study the sex–cadmium interaction 
was not significant, but the effect estimate for 
urinary cadmium was larger among males. A 
fourth study reported no association between 
LD and blood cadmium in the 1999–2000 
NHANES data (Lee et al. 2007). Cadmium 
accumulates in the kidney, and urinary cad-
mium concentration is considered to be a 
marker of cumulative exposure/body burden, 
whereas blood cadmium is thought to be a 
better indicator of recent exposure (Lauwerys 
et al. 1994). The different exposure metric 
used in the Lee et al. (2007) study may help 
explain the discrepancy in our findings.
In addition to higher odds of LD, we 
found that children in the highest quartile 
of urinary cadmium also had higher odds of 
Figure 1. The co-occurrence of neurodevelopmen-
tal outcomes in the study population among the 
2,183 participants with information on all three out-
comes (99% of the 2,199 participants).
n = 49
n = 1,771
Total with complete 
diagnosis information
n = 2,183
(99% of the 2,199 participants)
n = 14
n = 70
n = 78
n = 39
n = 98
n = 64
Special
education
ADHD
LD
No diagnosis
Table 1. Urinary cadmium concentration by demographic and covariate category.a
aValues for the study population, not weighted for oversampling. bHemoglobin levels for age and sex based on informa-
tion from Ahsan and Noether (2011): low hemoglobin, < 10th percentile; normal/high hemoglobin, ≥10th percentile.
Variable n
Median urinary Cd 
[μg/L (IQR)]
Age (years)
6–7 339 0.078 (0.038–0.139)
8–9 363 0.093 (0.050–0.151)
10–11 345 0.107 (0.058–0.180)
12–13 582 0.120 (0.062–0.199)
14–15 570 0.146 (0.071–0.220)
Urinary creatinine (mg/dL)
8–78 541 0.052 (0.030–0.090)
79–117 551 0.090 (0.050–0.140)
118–174 553 0.130 (0.081–0.182)
175–614 554 0.201 (0.139–0.300)
Poverty income ratio
0.00–0.82 514 0.130 (0.068–0.219)
0.83–1.51 502 0.110 (0.060–0.184)
1.52–2.99 507 0.105 (0.057–0.160)
3.00–5.00 507 0.090 (0.042–0.170)
Missing 169 0.124 (0.068–0.199)
Blood lead (μg/dL)
0.2–0.8 489 0.095 (0.048–0.169)
0.9–1.2 469 0.111 (0.061–0.180)
1.3–1.9 532 0.110 (0.055–0.197)
2.0–57.1 496 0.122 (0.061–0.201)
Missing 213 0.100 (0.057–0.165)
Hemoglobinb
Low 234 0.120 (0.061–0.207)
Normal/high 1,751 0.110 (0.057–0.182)
Missing 214 0.100 (0.057–0.165)
Race/ethnicity
White 578 0.081 (0.040–0.150)
Black 712 0.137 (0.076–0.220)
Mexican 729 0.110 (0.060–0.172)
Other Hispanic 90 0.096 (0.051–0.199)
Other race 90 0.113 (0.059–0.210)
Variable n
Median urinary Cd 
[μg/L (IQR)]
Sex
Male 1,144 0.110 (0.055–0.180)
Female 1,055 0.110 (0.060–0.183)
Serum cotinine (ng/mL)
0.011–0.034 419 0.097 (0.050–0.170)
0.035–0.079 546 0.111 (0.059–0.188)
0.080–0.503 484 0.110 (0.053–0.188)
0.509–402.0 483 0.120 (0.070–0.193)
Missing 267 0.100 (0.058–0.165)
Smoker in the home
Yes 477 0.112 (0.062–0.193)
No 1,697 0.110 (0.056–0.180)
Missing 25 0.109 (0.067–0.140)
Mother smoked while pregnant
Yes 354 0.100 (0.052–0.169)
No 1,815 0.110 (0.058–0.185)
Missing 30 0.068 (0.063–0.177)
Mother’s age at birth (years)
15–20 521 0.128 (0.068–0.210)
21–24 545 0.114 (0.060–0.177)
25–29 528 0.096 (0.049–0.161)
30–44 550 0.103 (0.056–0.185)
Missing 55 0.119 (0.063–0.184)
Education of household reference person
≤ 9th grade 306 0.125 (0.062–0.197)
≥ 9th no diploma 472 0.120 (0.070–0.200)
High school graduate/
equivalent
531 0.104 (0.055–0.174)
Some college/associate 
arts degree
519 0.110 (0.054–0.180)
College graduate 295 0.081 (0.039–0.150)
Missing 76 0.118 (0.052–0.192)Cadmium exposure and neurodevelopmental outcomes
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special education placement. Special education 
is a “catch-all” outcome that likely involves 
a variety of neurocognitive and behavioral 
dysfunctions, including LDs such as reading 
difficulties, dyslexia, ADHD, and language/
communication disorders, as well as behavior 
problems, psychiatric conditions, and per-
haps some physical dysfunctions. The broad 
heterogeneous nature of both special educa-
tion and LD as outcome measures prevents 
inferences about specific learning or cognitive 
domains. We are not aware of prior epide-
miologic studies directly relating cadmium 
exposure and special education. However, 
any of the previously mentioned animal or 
human studies that link cadmium exposure 
to adverse neurobehavioral/neurocognitive or 
general health outcomes may be relevant here, 
because these outcomes could lead to special 
education placement.
There are data supporting the biological 
plausibility of cadmium exposure as a risk 
factor for LD and special education place-
ment. For example, cadmium can inhibit the 
calcium flux required for neurotransmitter 
release (Hirning et al. 1988; Nation et al. 
1989) and might thereby disrupt the neural 
communication required for synaptic network 
formation during development. Cadmium 
has also been shown to influence the prolif-
eration and differentiation of neuroblasts in 
culture (Gulisano et al. 2009), and there is 
evidence that cadmium could indirectly affect 
the developing brain by disrupting thyroid 
hormone function (Iijima et al. 2007).
ADHD. Our findings for ADHD did not 
reach statistical significance, but the direc-
tion of the association suggests a possible 
decreased risk of ADHD diagnosis in children 
with urinary cadmium levels above the 25th 
percentile. There is only limited information 
from prior epidemiologic studies on cadmium 
exposure and ADHD/executive function. Lee 
et al. (2007) reported a non  significant trend 
of increasing odds of ADHD with increasing 
blood cadmium levels that was not present 
after adjustment for persistent organic pol-
lutants based on an analysis of 1999–2000 
NHANES data. As mentioned above, the dif-
ferent exposure metrics may partly explain the 
difference in our findings, because blood cad-
mium is a marker of recent exposure, whereas 
urine cadmium is a marker of chronic expo-
sure (Lauwerys et al. 1994). Cao et al. (2009) 
reported a non  significant trend of increasing 
problem behavior scores at 7 years of age with 
increasing blood cadmium levels measured 
at 2 years of age, but there were no obvious 
trends with increasing blood cadmium in the 
attention/executive subdomains, the hyper-
activity subdomain, or the ADHD index. The 
prospective approach is a strength of their 
study, but their unique population consisted 
solely of lead-poisoned children (blood lead 
levels of 20–44 μg/dL at enrollment), and the 
results may not be generalizable to non-lead-
poisoned children.
Previous animal-based studies have dem-
onstrated a variety of seemingly inconsistent 
effects of cadmium exposure on neurophysiol-
ogy and activity levels. These findings include, 
for example, reduced exploratory activity 
and decreased time spent moving, but they 
also include hyperactivity, and evidence of 
changes in central nervous system dopamine 
and serotonin metabolism (Ali et al. 1986; 
Desi et al. 1998; Nation et al. 1989, 1990). 
These two neurotransmitter systems have been 
implicated in the etiology of ADHD (Faraone 
et al. 2005). The varied direction of effects 
on activity level seen in the animal literature 
might be related to differences in the timing 
of cadmium exposure during neurodevelop-
ment, the presence of other uncontrolled vari-
ables, and/or the specific phenotype measured 
in each study. We lack detailed information 
on exposure timing, which makes it diffi-
cult to interpret the direction of the ORs for 
ADHD in the context of the animal litera-
ture (Andersen and Navalta 2004). If elevated 
cadmium exposure decreased activity levels, 
this may have made ADHD diagnosis less 
likely. It is also possible that cadmium may 
cause other neurocognitive dysfunctions that 
serve as competing risks to ADHD diagno-
sis (perhaps children with other diagnostic 
labels were less likely to receive an ADHD 
label), and the potential influence of chance 
should not be overlooked. Because these are 
cross-sectional data, the temporal relationship 
Table 2. Urinary cadmium concentration by outcome status.a
Outcome  n (% total) Median urinary Cd [μg/L (IQR)]
LD
Yes 276 (12.6) 0.130 (0.063–0.213)
No 1,913 (87.0) 0.107 (0.056–0.179)
Missing/refused/don’t know 10 (0.5) 0.115 (0.070–0.210)
Special education
Yes 231 (10.5) 0.130 (0.070–0.215)
No 1,965 (89.4) 0.108 (0.056–0.180)
Missing/refused/don’t know 3 (0.1) 0.059 (0.000–0.170)
ADHD
Yes 198 (9.0) 0.100 (0.048–0.167)
No 1,997 (90.8) 0.110 (0.060–0.182)
Missing/refused/don’t know 4 (0.2) 0.121 (0.033–0.247)
aValues for the study population, not weighted for oversampling. 
Table 3. ORs (95% CIs) for neurodevelopmental outcomes by quartile of urinary cadmium concentration.
Odds ratio (95% CI)
Urinary Cadmium (μg/L) Adjusted for creatinine onlya  Fully adjustedb
LD
Quartile 1 (0.0000–0.0576) 1 (reference) 1 (reference)
Quartile 2 (0.0580–0.1097) 1.06 (0.63, 1.79) 0.98 (0.53, 1.79)
Quartile 3 (0.1100–0.1800) 1.56 (0.83, 2.91) 1.72 (0.88, 3.37)
Quartile 4 (0.1802–14.9400) 2.44 (1.09, 5.44) 3.21 (1.43, 7.17)
Special education
Quartile 1 (0.0000–0.0576) 1 (reference) 1 (reference)
Quartile 2 (0.0580–0.1097) 1.51 (0.85, 2.69) 1.49 (0.80, 2.76)
Quartile 3 (0.1100–0.1800) 1.90 (0.77, 4.67) 2.15 (0.78, 5.93)
Quartile 4 (0.1802–14.9400) 2.41 (1.12, 5.18) 3.00 (1.12, 8.01)
ADHD
Quartile 1 (0.0000–0.0576) 1 (reference) 1 (reference)
Quartile 2 (0.0580–0.1097) 0.58 (0.32, 1.04) 0.50 (0.25, 0.98)
Quartile 3 (0.1100–0.1800) 0.62 (0.32, 1.23) 0.52 (0.23, 1.19)
Quartile 4 (0.1802–14.9400) 0.58 (0.26, 1.31) 0.67 (0.28, 1.61)
aUrinary creatinine included as an independent covariate in the models. bCovariates included in the models: urinary 
creatinine, age, sex, blood lead, smoker in the home, serum cotinine, prenatal smoke exposure (mother smoked while 
pregnant), and poverty income ratio. LD model also included education level of household reference person. Special 
education model also included race/ethnicity, preschool attendance, and education level of household reference per-
son. ADHD model also included race/ethnicity, mother’s age at birth, preschool attendance, and insurance coverage.
Table 4. Fully adjusted ORs (95% CIs) associated with a one-quartile increase in urinary cadmium 
  concentration.
Stratum LD Special education  ADHD
Study population 1.51 (1.14, 2.00) 1.44 (1.03, 2.01) 0.84 (0.61, 1.16)
Below median lead 1.67 (1.09, 2.56) 1.74 (0.91, 3.30) 1.11 (0.65, 1.91)
Above median lead 1.39 (0.98, 1.95) 1.29 (0.83, 2.01) 0.73 (0.52, 1.03)
Female 1.24 (0.75, 2.04) 1.31 (0.81, 2.13) 0.91 (0.50, 1.69)
Male 1.75 (1.24, 2.46) 1.73 (1.02, 2.92) 0.79 (0.56, 1.11)Ciesielski et al.
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between exposure and outcome is not dis-
cernable, and it is possible that urinary cad-
mium concentration tended to decrease after 
ADHD diagnosis (e.g., children with ADHD 
may be more likely to have behaviors that 
decrease cadmium exposure, absorption, or 
excretion). In the lead-stratified analysis, we 
found evidence that the OR for ADHD is 
< 1 only among those with blood lead levels 
above the median. The interaction was not 
significant, but there is toxicologic evidence 
that cadmium exposure may attenuate lead-
mediated increases in activity (Nation et al. 
1990). Further research is needed to clarify 
these issues.
Implications for cadmium risk assess-
ments. Previous cadmium risk assessments 
have considered renal effects to be the most 
sensitive end point of cadmium toxicity, and 
they identified urinary cadmium threshold 
levels that should protect against renal damage 
[EFSA 2009; World Health Organization/
Food and Agriculture Organization of the 
United Nations (WHO/FAO) 2011]. Recent 
risk assessments by the European Food Safety 
Authority (EFSA 2009) and the WHO 
(WHO/FAO 2011) yielded urinary cadmium 
reference levels of 1 and 5.24 μg cadmium/g 
creatinine, respectively. When we excluded 
from the analyses the four study participants 
with urinary cadmium levels above the EFSA 
reference level, the associations between uri-
nary cadmium and LD/special education were 
still evident (comparing the highest and lowest 
urinary cadmium quartiles: LD, OR = 3.25; 
95% CI: 1.45, 7.28; special education, OR = 
3.03; 95% CI: 1.14, 8.08). Thus, our work 
demonstrates associations with LD/special 
education at urinary cadmium levels below 
both the WHO and EFSA reference levels.
If these associations are replicated in other 
populations, then neurodevelopmental toxic-
ity may be a sensitive end point to consider in 
future cadmium risk assessments. The EFSA 
and WHO risk assessments used toxicokinetic 
models to link creatinine-standardized urinary 
cadmium levels to dietary cadmium intake 
in order to estimate dietary intake standards 
(Amzal et al. 2009; EFSA 2009; WHO/FAO 
2011). These toxicokinetic models were vali-
dated in adults (Amzal et al. 2009), but they 
are probably not appropriate to use among 
children, because exposure routes may differ 
(Weidenhamer et al. 2011) and because urinary 
creatinine concentration varies markedly with 
small increases in age among children (Barr 
et al. 2005). Recent work by Weidenhamer 
et al. (2011) suggests that mouthing or acci-
dentally swallowing objects such as inexpensive 
jewelry may also contribute significantly to 
cadmium exposure in childhood. The extent to 
which these sources contributed to cadmium 
exposure in our population is unknown, but 
future risk assessments should not ignore the 
potential impact of non-food-based exposures 
or that current toxicokinetic models are not 
child specific.
Strengths and limitations. Exposure. The 
use of urinary cadmium as an exposure metric 
is a strength of this study. Urinary cadmium 
integrates exposure over many years (Lauwerys 
et al. 1994); thus, if brain development is sen-
sitive to cadmium exposure in any of the time 
periods represented by this exposure metric, 
then this effect could be detected in our analy-
sis. However, it is not possible to determine 
etiologically relevant time windows of exposure 
or to confirm the temporal sequence of expo-
sure and outcomes based on the available data. 
A shorter time-course exposure metric such 
as blood cadmium (Lauwerys et al. 1994), in 
the context of a longitudinal prospective study 
that measures exposure and outcome at several 
time points, may be able to determine if the 
associations are driven by exposure that occurs 
in specific developmental windows.
Outcomes. We believe the diversity of 
outcomes evaluated is a strength of this study, 
because the combination of these three out-
comes constitutes a screen for common neu-
rodevelopmental dysfunctions. One limitation 
of these outcome measures is that they were 
derived from parent or proxy-respondent 
reports rather than neuropsychological evalua-
tions. The use of ADHD treatments as an out-
come would have likely identified only a subset 
of ADHD cases, resulting in low case num-
bers and analyses of limited power (Froehlich 
et al. 2007). Neuropsychiatric screening mea-
sures, such as the National Institute of Mental 
Health Diagnostic Interview Scale for Children 
that includes assessment of criteria for ADHD 
based on the 4th edition of the Diagnostic and 
Statistical Manual of Mental Disorders (CDC-
NCHS 2006; Froehlich et al. 2009), would 
have been more objective, but these outcomes 
were not present in the publicly available 
NHANES data. Although outcomes were 
classified based on proxy-respondent reports, 
it is unlikely that outcome misclassification 
would be differential with respect to exposure 
unless the accuracy of reporting was related to 
unmeasured factors associated with cadmium 
exposure. Typically, non  differential misclassi-
fication would be expected to bias associations 
toward the null (Rothman et al. 2008).
Confounding. The extensive covariate data 
available in NHANES, combined with the large 
sample size and high number of cases, allowed 
us to both evaluate and account for many 
potentially confounding variables. We sought 
to evaluate the association of cadmium exposure 
with the outcomes after accounting for other 
known correlates of the outcomes. We evalu-
ated three sets of models: a) models adjusted 
only for creatinine, b) core models adjusted 
for primary potential confounders, and c) full 
models also adjusted for additional predictors 
of a priori interest. The conclusions from all 
three of these approaches were consistent. We 
further note that adjusting for iron deficiency 
using low hemoglobin had little effect on the 
results and does not alter the conclusions of this 
study (data not shown). As in any observational 
epidemiology study, we cannot rule out the 
possibility that confounding may have mean-
ingfully affected our results. Potential sources of 
confounding in these analyses might include a 
lack of detailed information on the home envi-
ronment (Bradley 1993) and parental psycho-
pathology (Bellinger 2001).
Study design. The cross-sectional design 
of NHANES is a limitation of this study, 
because the temporal relationships between 
variables are not discernable. It is possible 
that higher cadmium exposure puts children 
at greater risk of LD/special education, but it 
is also possible that children with LD/special 
education have behaviors or prefer foods that 
increase their cadmium exposure. However, 
we are unaware of evidence supporting this 
reverse causation explanation.
The NHANES study design does offer 
strengths related to power and generaliz-
ability. To our knowledge, this is the largest 
study to evaluate associations between urinary 
cadmium and childhood learning/behavioral 
phenotypes. Because NHANES was designed 
to represent the non  institutionalized U.S. 
population (CDC-NCHS 2010b), our find-
ings should be generalizable to U.S. children 
6–15 years of age.
Conclusions
The results of this study are consistent with 
a growing body of evidence suggesting that 
elevated cadmium exposure may be associ-
ated with LD and special education. However, 
given the cross-sectional design and the nature 
of parent-reported outcomes, interpretations 
should be cautious. Prospective epidemio-
logic investigations and behavioral toxicol-
ogy studies in animals could help to clarify if 
these associations are causal and if there are 
critical developmental windows for exposure. 
Prospective studies that consider co-exposures 
such as lead may also help reveal why the find-
ings for LD/special education and ADHD 
differed. Given that the cadmium levels in this 
study represent typical exposure levels in U.S. 
children, our findings emphasize the need for 
further research into the potential neuro-
developmental effects of cadmium exposure.
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